Skip to main content
Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.294
-0.018 (-5.67%)
At close: Dec 20, 2024, 4:00 PM
0.260
-0.034 (-11.68%)
After-hours: Dec 20, 2024, 7:59 PM EST

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $1.58M in the quarter ending September 30, 2024, a decrease of -5.87%. This brings the company's revenue in the last twelve months to $4.02M, down -42.41% year-over-year. In the year 2023, Petros Pharmaceuticals had annual revenue of $5.82M, down -2.83%.

Revenue (ttm)
$4.02M
Revenue Growth
-42.41%
P/S Ratio
0.45
Revenue / Employee
$191,542
Employees
21
Market Cap
2.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 201915.58M1.53M10.86%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
iCoreConnect 11.05M
ReShape Lifesciences 8.18M
China Pharma Holdings 5.54M
Lipella Pharmaceuticals 483.53K
60 Degrees Pharmaceuticals 462.61K
Aditxt 212.11K
Alaunos Therapeutics 7.00K
Revenue Rankings

PTPI News

More News